Panelists discuss how differing disease mechanisms, inflammatory drivers, and clinical priorities across AMD, DME, and RVO ...

The FDA approved Eylea HD for the treatment of macular edema following retinal vein occlusion, according to a press ...

Home OCT and AI significantly improve early detection and treatment adjustments in neovascular AMD, enhancing patient ...

Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) today announced data from a post hoc analysis of the GALE extension study ...

Cadmus C. Rich, MD, MBA, as Chief Medical Officer, and Carlos Quezada-Ruiz, MD, FASRS, as Chair of the Scientific Advisory Board, bring ...

Lotery cautioned that AI's use in eye care has limitations. "AI models may underperform on underrepresented populations, AI trained on specific datasets may not transfer well across clinical settings, ...

In this video from the American Academy of Ophthalmology meeting, Diana V. Do, MD, said aflibercept 8 mg showed vision improvement and a reduction in retinal thickness.

Kodiak Sciences Inc. (Nasdaq: KOD), today reported recent business highlights and financial results for the third quarter ended September 30, 2025.

Discover Harrow Inc.'s growth strategy, bullish long-term prospects, and Q3 earnings outlook in ophthalmology. Click for more on HROW stock ahead of earnings.

Third Quarter 2025 Financial Highlights - Cash Position: Cash and cash equivalents were $81.3 million as of September 30, 2025, compared to $90.4 million as of June 30, 2025. - Revenue: ...